LONDON, Nov 25 (Reuters) - Immupharma Plc:
* Signs a $15 million option agreement for late- stage experimental lupus
medication with Cephalon
((London Equities Newsroom; +44 20 7542 7717))
(For more news, please click here)
COPYRIGHT
Copyright Thomson Reuters 2008. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including
by framing or similar means, is expressly prohibited without the prior written
consent of Thomson Reuters.
|